The influence of the 5-HT 3 receptor antagonist tropisetron on pain in fibromyalgia: A functional magnetic resonance imaging pilot study

Scandinavian Journal of Rheumatology, Supplement

Volumn 33, Issue 119, 2004, Pages 24-27

  Koeppe, C ^a   Schneider, C ^a   Thieme, K ^b   Mense, S ^a   Stratz, T ^c   Muller W ^c   Flor, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Hochrhein Institut   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; PRILOCAINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON; INDOLE DERIVATIVE; SEROTONIN RECEPTOR;

ADULT; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FIBROMYALGIA; HUMAN; INSULA; MECHANICAL STIMULATION; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN METABOLISM; SOMATOSENSORY CORTEX; ARTICLE; BRAIN; MIDDLE AGED; PATHOPHYSIOLOGY;

BRAIN; FEMALE; FIBROMYALGIA; HUMANS; INDOLES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; RECEPTORS, SEROTONIN;

EID: 4444262689     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410006989     Document Type: Conference Paper

References (12)

1. Wolfe F, Stnythe HA, Yunus MB, Bennett RM, Bombardier C. Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Gibson SJ, Littlejohn GO, German MM, Helme RD, Granges G. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994;58:185-93.
3. Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 1998;57 Suppl. 2:19-22.
4. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-4.
5. 3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996;208:203-7.
6. Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/ hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 2000;85:31-9.
7. Ernberg M, Voog U, Alstergren P, Lundeberg T, Kopp S. Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. J Orofac Pain 2000;14:37-46.
8. Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N, et al. Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 2002;11:434-42.
9. Papadopoulos IA, Georgiou PE, Katsimbri PP, Drosos AA. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Clin Rheumatol 2000;19:6-8.
10. Stratz T, Farber L, Varga B, Baumgartner C, Haus U, Muller W. Fibromyalgia treatment with intravenous tropisetron administration. Drugs Exp Clin Res 2001;27:113-8.
11. Stratz T, Muller W. Die Schmerzbeeinflussung durch den 5-HT3-Rezeptorantagonisten Tropisetron bei sekundaren Fibromyalgien. Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias. Fortschr Med Orig 120, 2002, 17-20.
12. Stratz T, Muller W. Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron. Schmerz 17, 2003, 200-3.